Author: Robert Peter Gale,Dieter Hoelzer
Publisher: Bailliere Tindall; New edition edition (June 1994)
Category: Medicine & Health Sciences
Size Fb2: 1420 kb
Size ePub: 1739 kb
Size Djvu: 1453 kb
Other formats: txt mobi azw lrf
Imprint BAILLIERE TINDALL. Publication City/Country London, United Kingdom.
A guide to the diagnosis and detection of acute lymphoblastic leukaemia, detailing genetic changes and associated morphological and cytochemical alterations. Imprint BAILLIERE TINDALL.
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain.
Главная American Journal of Clinical Oncology Acute Lymphoblastic Leukemia. American Journal of Clinical Oncology 1991, 02 Vol. 14; Iss. 1. Acute Lymphoblastic Leukemia. Gale, Robert Peter, Hoelzer, Dieter, Kantarjian, Hagop M. Volume: 14. Journal: American Journal of Clinical Oncology. Date: February, 1991.
Acute Lymphoblastic Leukaemia. Article · March 2014 with 60 Reads. How we measure 'reads'. Eligible patients were categorised into clinical standard, intermediate, and high risk groups on the basis of a combination of National Cancer Institute (NCI) criteria, cytogenetics, and early response to induction therapy, which was assessed by bone marrow blast counts taken at days 8 (NCI high-risk patients) and 15 (NCI standard-risk patients) after induction began.
Are you looking for a regimen, but can't find it here? It is possible that we've moved it to the historical regimens page. T-cell acute lymphoblastic leukemia. Please note, mature B-cell ALL (L3) is now classified as Burkitt lymphoma/leukemia.
Acute lymphoblastic leukemia (ALL) encompasses a group of lymphoid . The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981;47(4):553–61.
Acute lymphoblastic leukemia (ALL) encompasses a group of lymphoid neoplasms that morphologically and resemble B-lineage and T-lineage precursor cells. These neoplasms may present predominantly as a leukemic process, with extensive involvement of the bone marrow and peripheral blood or may be limited to tissue infiltration, with absent or only limited (less than 25%) bone marrow involve-ment.
Hoelzer D: Acute lymphoblastic leukemia – progress in children, less in adults
Hoelzer D: Acute lymphoblastic leukemia – progress in children, less in adults. N Engl J Med 329: 1343, 1993. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Rühl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Müller U, Lunscken C, Fülle H, Ho AD, Küchler R, Busch FW, Schneider W, Görg C, Emmerich B, Braumann D, Vaupel HA, Paleske A, Bartels H, Neiss A, Messerer D: Prognostic.
Of the 300 patients with acute lymphoblastic leukemia, studied molecular genetics techniques in the biochip laboratory . Ryazan Medical University named after . Pavlov; 2Ryazan Regional Children's Clinical Hospital named after .
Of the 300 patients with acute lymphoblastic leukemia, studied molecular genetics techniques in the biochip laboratory diagnostics in 13 patients was identified t(9;22) BCR, ABL p190. Based on clinical and laboratory data was diagnosed Ph-positive acute lymphoblastic leukemia. Parents of 3 patients (2. %) refusal of chemotherapy. iНе можете найти то, что вам нужно? Попробуйте сервис подбора литературы.
For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Br J Haematol 47 (4): 553-61, 1981. Koehler M, Behm FG, Shuster J, et al.
Acute Myelogenous Leukemia : Progress and Controversies. The inclusion of experimental and clinical data in a single volume, together with an emphasis on recent and controversial issues, combine to make this treatise unique in its approach to acute myelogenous leukemia (AML). Investigators from diverse disciplines critically examine what is now understood about the pathogenesis of this disease and discuss new and emerging therapeutic approaches.